WuXi Biologics added to FTSE4Good Index Series for sixth straight yearPUBT·2 days ago, 09:28 PMWXXWY+1.86%02269+2.49%
WuXi Biologics Recognized by FTSE4Good for the Sixth Consecutive Year, Underscoring Value Creation Through Green CRDMOPR Newswire·2 days ago, 09:27 PMWXXWY+1.86%02269+2.49%
Nomura Raises WUXI BIO TP to HKD51.38, Estimates 1H Profit to Drop 15%AASTOCKS News·Jul 27 at 02:22 AMWXXWY+1.86%02269+2.49%
WuXi Biologics schedules board meeting to review interim resultsPUBT·Jul 24 at 03:32 AMWXXWY+1.86%02269+2.49%
The 2026 Pick-and-Shovel Illusion: Who Is Actually Building the Future?Global Report·Jul 21 at 04:13 AMVMC-0.98%MLM-2.75%
SDIC Securities Keeps Their Buy Rating on Wuxi Biologics (Cayman) (WXIBF)Tip Ranks·Jul 17 at 04:55 AM02269+2.49%WXXWY+1.86%
CANbridge Calls Virtual EGM to Approve WuXi Biologics Service FrameworkTip Ranks·Jul 15 at 09:38 AM012280.00%WXXWY+1.86%
UBS: CN CRO Sees Solid Revenue Growth in 1H; WUXI APPTEC Top PickAASTOCKS News·Jul 14 at 02:56 AM02269+2.49%02359+1.90%
UBS' Investment Ratings and TPs on CRO Stocks (Table)AASTOCKS News·Jul 14 at 02:00 AM300759+2.19%02268+1.47%
Analysts Offer Insights on Healthcare Companies: Wuxi Biologics (Cayman) (OtherWXIBF) and Community Health (CYH)businessinsider·Jul 11 at 03:00 AMWXXWY+1.86%02269+2.49%
CANbridge Pharmaceuticals delays EGM circular dispatch to on or before July 20, 2026PUBT·Jul 9 at 03:32 AM012280.00%WXXWY+1.86%
WuXi Biologics' MFG8 Drug Substance Facility Secures FDA PLI Approval, Advancing Commercial Supply of a Potential Blockbuster Autoimmune TherapyUnusual Whales·Jul 9 at 02:34 AM02269+2.49%WXXWY+1.86%
